VNDA – vanda pharmaceuticals inc. (US:NASDAQ)

News

Vanda (VNDA) Rises on Positive Data From Motion Sickness Study [Yahoo! Finance]
Vanda Pharmaceuticals reports positive data from motion sickness trial [Yahoo! Finance]
Vanda Pharmaceuticals Reports Positive Results from a Second Phase III Study of Tradipitant in Motion Sickness [Yahoo! Finance]
Vanda Pharmaceuticals Reports Positive Results from a Second Phase III Study of Tradipitant in Motion Sickness
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com